Considering gemcitabine‐based combination chemotherapy as a potential treatment for advanced oesophageal cancer: A meta‐analysis of randomised trials

医学 吉西他滨 荟萃分析 化疗 肿瘤科 内科学 癌症
作者
Jian Yang,Xiao Liang,Yuanfang Zhai,Xiao Hu,Zhiwu Jia,Xiaolong Cheng
出处
期刊:International Journal of Clinical Practice [Wiley]
卷期号:74 (7) 被引量:5
标识
DOI:10.1111/ijcp.13510
摘要

Background Gemcitabine has been proved to be effective in many advanced cancer. However, almost all trials failed to demonstrate the response rate of gemcitabine-based combination schedules on oesophageal cancer (EC). Methods A systematic meta-analysis of randomised clinical trials (RCTs) was performed to investigate the efficacy of gemcitabine-based combination chemotherapy in EC treatment. Clinical trials were collected during the period ranging from January 2000 to November 2018 by searching different databases. Odds-ratios (ORs) of response rate (RR), disease control rate (DCR) and grade 3-4 toxicity rates (TRs) were extracted as presented in retrieved studies. Results Fourteen trials (1024 patients) were selected for the final analysis. The results showed that RR and DCR of gemcitabine-based combination chemotherapy demonstrated a significant advantage for non-gemcitabine therapy (OR for RR: 1.51; 95% CI: 1.16-1.96; P = .002; OR for DCR: 1.66; 95% CI: 1.19-2.32, P = .003). Toxicities of gemcitabine-based combination chemotherapy on gastrointestinal tract (OR, 0.39; 95% CI: 0.24-0.63, P = .0001) were less frequent compared to that of the non-gemcitabine therapy. Conclusion The improvements of gemcitabine-based combination chemotherapy on RR, CDR and reduction of gastrointestinal tract, hepatic and renal for EC patients suggests that the combined chemotherapy based on gemcitabine could be a potential treatment options for advanced EC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
英俊白莲发布了新的文献求助10
2秒前
OMR123完成签到,获得积分10
3秒前
西瓜完成签到,获得积分10
3秒前
3秒前
3秒前
yuC发布了新的文献求助30
4秒前
科研通AI5应助左肩微笑采纳,获得10
4秒前
5秒前
5秒前
辛某发布了新的文献求助10
5秒前
吴军霄完成签到,获得积分10
6秒前
7秒前
豆豆完成签到 ,获得积分10
8秒前
展希希发布了新的文献求助10
8秒前
万能图书馆应助缥缈冬寒采纳,获得10
8秒前
vv发布了新的文献求助10
9秒前
汉堡包应助chiweiyoung采纳,获得10
9秒前
11秒前
12秒前
一支布洛芬完成签到,获得积分20
12秒前
12秒前
香蕉觅云应助英俊白莲采纳,获得10
12秒前
英俊的铭应助树精采纳,获得10
14秒前
Ava应助yummy采纳,获得10
14秒前
YJ888发布了新的文献求助10
14秒前
可爱的函函应助lzx采纳,获得10
16秒前
16秒前
gulllluuuukk完成签到,获得积分10
18秒前
Lynn怯霜静完成签到,获得积分10
19秒前
科研通AI5应助青青子衿采纳,获得10
20秒前
孙燕应助lalala采纳,获得50
20秒前
21秒前
21秒前
斯文念波发布了新的文献求助10
22秒前
25秒前
辛某完成签到,获得积分10
25秒前
香蕉觅云应助期刊采纳,获得50
26秒前
26秒前
26秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989550
求助须知:如何正确求助?哪些是违规求助? 3531774
关于积分的说明 11254747
捐赠科研通 3270278
什么是DOI,文献DOI怎么找? 1804966
邀请新用户注册赠送积分活动 882125
科研通“疑难数据库(出版商)”最低求助积分说明 809176